New targets for antiviral therapy of chronic hepatitis C.
about
Intrinsically unstructured domain 3 of hepatitis C Virus NS5A forms a "fuzzy complex" with VAPB-MSP domain which carries ALS-causing mutationsHepatitis C virus NS5B and host cyclophilin A share a common binding site on NS5ALipid droplet-binding protein TIP47 regulates hepatitis C Virus RNA replication through interaction with the viral NS5A proteinRecent advances in managing chronic HCV infection: focus on therapy in patients with severe liver diseaseEntry inhibitors: New advances in HCV treatmentOral antiviral therapies for chronic hepatitis C infectionThe crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitorsProbing of exosites leads to novel inhibitor scaffolds of HCV NS3/4A proteinaseVAPC, an human endogenous inhibitor for hepatitis C virus (HCV) infection, is intrinsically unstructured but forms a "fuzzy complex" with HCV NS5B.Replication-competent infectious hepatitis B virus vectors carrying substantially sized transgenes by redesigned viral polymerase translation.Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection.Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys.Interplay between Hepatitis C Virus and Redox Cell Signaling.Hepatitis C virus infection, microRNA and liver disease progressionHost-targeting agents in the treatment of hepatitis C: a beginning and an end?Current progress in the treatment of chronic hepatitis C.Treatment of hepatitis C virus genotype 3-infection.The Role of MicroRNA in Hepatitis C Virus ReplicationEpidermal growth factor receptor signaling impairs the antiviral activity of interferon-alpha.Treatment of experienced and naïve patients with hepatitis C: focus on telaprevir.Chemical genetics-based development of small molecules targeting hepatitis C virus.4th European Seminars in Virology on Oncogenic and Oncolytic Viruses, in Bertinoro (Bologna), Italy.MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis.All for one, one for all: new combinatorial RNAi therapies combat hepatitis C virus evolution.Interferon-based combination treatment for chronic hepatitis C in the era of direct acting antivirals.[Hepatitis C virus: 25 years-old, the end?].
P2860
Q21560973-EA3D771C-649D-455F-9A2C-61E1C717F9C1Q24303838-A3DEA59F-67C9-4B1A-93D4-64EE811A7F2AQ24338608-33DA3586-60CF-4EF2-BDC1-7657A4FE01E4Q26752433-44A012EA-34AA-40B0-910A-2FD298AF4D0BQ26770817-0AE5135E-87DA-4618-B958-69C9635CB3C2Q26830426-8C9CB031-94AD-412E-9F7A-99A825C71716Q27682272-D1EEA444-C53F-4273-B7BE-D6A106815603Q28480947-2ECF0CCD-FAD8-4E25-9818-EF2D307E2B20Q30155273-9F3250E9-DCFF-4F8C-89B9-82676BFB91EFQ34669990-D782C98A-7031-46DF-8F80-4544EBFF9058Q35125004-B19DE6FC-A3E4-422B-86CD-401A97ACE996Q35910008-FBDFF34C-ADB7-4662-811F-329B3A5EED55Q36790471-74AFF3D8-50C2-41E9-B71E-BF865261E120Q37196517-B8BDBE32-58BC-441D-94E1-1B22BAB13522Q37676364-CD5886C7-6AE9-472D-A7D2-BFE3DE25E019Q38060117-290E6870-C58C-43DC-B1AE-1430EFF73FDDQ38174244-2BADFC33-6163-431D-BD48-DCAFB6244FEFQ38584077-EDEB9FF6-A25B-4BB8-8BE8-B92E50F1ACDCQ39177270-60509906-524B-41A9-A317-D26389559A78Q39526702-4DC323EF-A46B-49CA-9E39-223433349F87Q40063790-36BF560C-B08B-4756-A799-53B8A67E7335Q40470227-19ACD63A-B743-474A-BFC2-CE01AC7603FFQ42269945-686D433D-F891-4B2B-8F87-7B31BA191DD7Q42324176-690CA352-7324-4764-8E16-88D2D4800938Q43100552-940BDD05-76F2-4650-800B-842A99A882C3Q44199367-84D7DF16-27DC-48B5-AF06-A6C2ECF7FAFB
P2860
New targets for antiviral therapy of chronic hepatitis C.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
New targets for antiviral therapy of chronic hepatitis C.
@en
New targets for antiviral therapy of chronic hepatitis C.
@nl
type
label
New targets for antiviral therapy of chronic hepatitis C.
@en
New targets for antiviral therapy of chronic hepatitis C.
@nl
prefLabel
New targets for antiviral therapy of chronic hepatitis C.
@en
New targets for antiviral therapy of chronic hepatitis C.
@nl
P2860
P1433
P1476
New targets for antiviral therapy of chronic hepatitis C.
@en
P2093
Sandra Bühler
P2860
P356
10.1111/J.1478-3231.2011.02701.X
P478
32 Suppl 1
P577
2012-02-01T00:00:00Z